How to stay
How to stay
Antibiotic resistance is an increasing global problem. Xaga Surgical is a spinoff from Lund University developing new breed of medical needles that will save lives and health of patients in the era of antibiotic resistance.
6% of prostate biopsies results in infections and the rate is increasing
The Forsvall Needle
The idea of our needle is to effectively reduce the risk of severe sepsis by virtually eliminating bacterial transfer upon insertion. Compared to the needles used today, ex vivo puncture tests in the human colon have demonstrated a 96% reduction of the bacterial translocation with our needle.
The FORSVALL NEEDLE is expected to significantly increase safety during diagnose of prostate cancer and other diseases by reducing the risk of getting sepsis/infection after a biopsy. The estimated annual savings due to infection reduction when using our needles in over 200M€ in emergency cost for prostate cancer diagnosis alone.
On the basis of the existing patented technology of Xaga Surgical’s biopsy needle, our company is in the perfect position to exploit the market opportunity for a safe, cheap and easy-to-use biopsy needle that aims to reduce the risk of infection – a task no competitor has been able to succeed with.